Found: 32
Select item for more details and to access through your institution.
Sunitinib in Patients with Metastatic Renal Cell Carcinoma with Favorable Risk: Be Aware of PD-L1 Expression.
- Published in:
- Medical Sciences, 2024, v. 12, n. 3, p. 48, doi. 10.3390/medsci12030048
- By:
- Publication type:
- Article
RUSSCO-RSP comparative study of immunohistochemistry diagnostic assays for PD-L1 expression in urothelial bladder cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Hypercoagulability as a prognostic factor for survival in patients with metastatic renal cell carcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2009, v. 28, p. 1, doi. 10.1186/1756-9966-28-30
- By:
- Publication type:
- Article
Challenges of FGFR2 Testing in Gastric Cancer.
- Published in:
- Oncology Reviews, 2023, p. 1, doi. 10.3389/or.2023.11790
- By:
- Publication type:
- Article
Sunitinib treatment of metastatic renal cell carcinoma in von Hippel-Lindau disease.
- Published in:
- 2015
- By:
- Publication type:
- case study
Treatment options for renal cell carcinoma in patients with von Hippel-Lindau disease.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
Nivolumab in patients with metastatic renal cell carcinoma and chronic hepatitis C virus infection.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 983, doi. 10.1007/s00262-020-02521-y
- By:
- Publication type:
- Article
Nivolumab: 5 Years Since FDA Approval of the First Checkpoint Inhibitor for Renal Cell Carcinoma.
- Published in:
- Kidney Cancer (2468-4562), 2021, v. 5, n. 2, p. 63, doi. 10.3233/KCA-200109
- By:
- Publication type:
- Article
Overall survival in patients with metastatic renal cell carcinoma in Russia, Kazakhstan, and Belarus: a report from the RENSUR3 registry.
- Published in:
- Cancer Reports, 2021, v. 4, n. 3, p. 1, doi. 10.1002/cnr2.1331
- By:
- Publication type:
- Article
Paraneoplastic vasculitis in patients with metastatic renal cell carcinoma.
- Published in:
- Cancer Reports, 2019, v. 2, n. 2, p. N.PAG, doi. 10.1002/cnr2.1142
- By:
- Publication type:
- Article
Safety and preliminary efficacy of the Gam-COVID-Vac vaccine and outcomes of SARS-CoV-2 infection in Russian patients with genitourinary malignancies.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01205-z
- By:
- Publication type:
- Article
Distribution of EGFR Mutations in 10,607 Russian Patients with Lung Cancer.
- Published in:
- Molecular Diagnosis & Therapy, 2016, v. 20, n. 4, p. 401, doi. 10.1007/s40291-016-0213-4
- By:
- Publication type:
- Article
Expression of Receptor Tyrosine Kinases on Peripheral Blood Mononuclear Cells and Tumor-Infiltrating Lymphocytes in Patients with Renal Cell Carcinoma and Healthy Donors.
- Published in:
- Oncology, 2020, v. 98, n. 4, p. 252, doi. 10.1159/000505373
- By:
- Publication type:
- Article
Fibroblast Growth Factor Receptor 1 as a Target for the Therapy of Renal Cell Carcinoma.
- Published in:
- Oncology, 2015, v. 88, n. 6, p. 321, doi. 10.1159/000370118
- By:
- Publication type:
- Article
Cholangiocarcinoma: An Emerging Target for Molecular Therapy.
- Published in:
- Gastrointestinal Tumors, 2021, v. 8, n. 4, p. 153, doi. 10.1159/000517258
- By:
- Publication type:
- Article
A phase 1b study of the allosteric extracellular FGFR2 inhibitor alofanib in patients with pretreated advanced gastric cancer.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 2, p. 324, doi. 10.1007/s10637-023-01340-z
- By:
- Publication type:
- Article
Alofanib, an allosteric FGFR2 inhibitor, has potent effects on ovarian cancer growth in preclinical studies.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 2, p. 127, doi. 10.1007/s10637-016-0404-1
- By:
- Publication type:
- Article
OM-RCA-01, a novel humanized monoclonal antibody targeting fibroblast growth factor receptor 1, in renal cell carcinoma model.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1436, doi. 10.1007/s10637-013-0017-x
- By:
- Publication type:
- Article
Patterns of Care and Barriers to Utilization of Definitive Concurrent Chemoradiation Therapy for Stage III Non-Small Cell Lung Cancer in Russia.
- Published in:
- Journal of Cancer Education, 2022, v. 37, n. 5, p. 1378, doi. 10.1007/s13187-021-01966-8
- By:
- Publication type:
- Article
Management of Muscle Invasive Bladder Cancer with Bladder Preservation in Russia: a Survey-Based Analysis of Current Practice and the Impact of an Educational Workshop on Clinical Expertise.
- Published in:
- Journal of Cancer Education, 2021, v. 36, n. 5, p. 1005, doi. 10.1007/s13187-020-01728-y
- By:
- Publication type:
- Article
Radiotherapy for Hepatocellular Carcinoma in Russia: a Survey-Based Analysis of Current Practice and the Impact of an Educational Workshop on Clinical Expertise.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Bridging the Gap in Global Advanced Radiation Oncology Training: Impact of a Web-Based Open-Access Interactive Three-Dimensional Contouring Atlas on Radiation Oncologist Practice in Russia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
First‐line checkpoint inhibitors in PD‐L1‐positive patients with advanced urothelial carcinoma.
- Published in:
- BJU International, 2019, v. 123, n. 4, p. 563, doi. 10.1111/bju.14627
- By:
- Publication type:
- Article
First‐line checkpoint inhibitors in PD‐L1‐positive patients with advanced urothelial carcinoma.
- Published in:
- BJU International, 2019, v. 123, n. 4, p. 563, doi. 10.1111/bju.14627
- By:
- Publication type:
- Article
Cytoreductive radiofrequency ablation in patients with metastatic renal cell carcinoma ( RCC) with small primary tumours treated with sunitinib or interferon-α.
- Published in:
- BJU International, 2013, v. 112, n. 1, p. 32, doi. 10.1111/bju.12107
- By:
- Publication type:
- Article
Intrapleural nivolumab in cancer patients with pleural effusion.
- Published in:
- Journal of Cancer Research & Therapeutics, 2024, v. 20, n. 3, p. 1036, doi. 10.4103/jcrt.jcrt_739_22
- By:
- Publication type:
- Article
Immunotherapy in cancer patients with chronic hepatitis C viral infection.
- Published in:
- Journal of Cancer Research & Therapeutics, 2023, v. 19, n. 5, p. 1093, doi. 10.4103/jcrt.jcrt_2095_21
- By:
- Publication type:
- Article
Adjuvant therapy for renal cell carcinoma in 2023: hopes and disappointments.
- Published in:
- World Journal of Urology, 2023, v. 41, n. 7, p. 1855, doi. 10.1007/s00345-023-04450-8
- By:
- Publication type:
- Article
Agreement between PDL1 immunohistochemistry assays and polymerase chain reaction in non-small cell lung cancer: CLOVER comparison study.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-60950-2
- By:
- Publication type:
- Article
Harmonization of Molecular Testing for Non-Small Cell Lung Cancer: Emphasis on PD-L1.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.549198
- By:
- Publication type:
- Article
Phase 2 Multicenter Single-Arm Study of Second-Line Axitinib in Favorable Risk Patients with Metastatic Renal Cell Carcinoma: FavorAx.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Everolimus in patients with metastatic renal cell carcinoma previously treated with bevacizumab: a prospective multicenter study CRAD001LRU02T.
- Published in:
- Targeted Oncology, 2015, v. 10, n. 3, p. 423, doi. 10.1007/s11523-014-0347-4
- By:
- Publication type:
- Article